1.Morris E., Hart D., Gao L. et al. Generation of tumor-specific T-cell therapies. Blood Rev. 2006; 20[2): 61-9.2.Ruggeri L., Mancusi A., Capanni M. et al. Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer. Curr. Opin. Immunol. 2005; 17[2): 211-7.3.Koehl U., Sorensen J., Esser R. et al. IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation. Blood Cells Mol. Dis. 2004; 33[3): 261-6.4.Cui Z., Willingham M.C., Hicks A.M. et al. Spontaneous regression of advanced cancer: identification of a unique genetically determined, age-dependent trait in mice. Proc. Natl. Acad. Sci. USA 2003; 100[11 ): 6682-7.